Characteristics and outcome of breast cancer-related microangiopathic haemolytic anaemia: a multicentre study.

Date publication

janvier 2021

Journal

Breast cancer research : BCR

Auteurs

Membres identifiés du Cancéropôle Est :
Dr LADOIRE Sylvain , Dr DESMOULINS Isabelle

Tous les auteurs :
Alhenc-Gelas M, Cabel L, Berger F, Delaloge S, Frenel JS, Levy C, Firmin N, Ladoire S, Desmoulins I, Heudel PE, Dalenc F, Loirat D, Dubot C, Vuagnat P, Deluche E, Mokdad-Adi M, Patsouris A, Annic J, Djerroudi L, Lavigne M, Pierga JY, Coppo P, Bidard FC

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/33468209

Résumé

Cancer-related microangiopathic haemolytic anaemia (MAHA) is a rare but life-threatening paraneoplastic syndrome. Only single cases or small series have been reported to date. We set up a retrospective multicentre study focusing on breast cancer-related MAHA.

Mots clés

Breast cancer, Microangiopathic haemolytic anaemia, Prognostic factors, Survival

Référence

Breast Cancer Res. 2021 Jan 19;23(1):9